HOME >> MEDICINE >> NEWS
Statins may inhibit calcium growth on aortic valve in the elderly

People who take statins may have at least 60 percent less aortic valve calcium than people who do not take statins, according to a University of Washington study in the March 30 edition of The Lancet.

"A large percentage of elderly people suffer from excess calcium in their aortic valve. Excessive calicum buildup can prevent the valve from opening normally. Because we currently have no way to treat them with medicine, heart surgery to replace the valve is the only solution when the buildup is severe. But it may well be that the use of statins could slow or inhibit development of the problem," says Dr. Kevin OBrien, an associate professor of medicine in the UW School of Medicines Division of Cardiology.

OBriens co-authors of the research letter include Drs. David Shavelle and Xue-Qiao Zhao, also from the UW Division of Cardology, and Drs. Junichero Takasu, Matthew J. Budoff and SongShou Mao, all of the Harbor-UCLA Research and Education Institute of Torrance, Calif.

It is already well known that statins cause improvement in arterial blockage and reduce the occurrence of major cardiovascular events. The question examined in the Lancet paper is whether they can help prevent aortic valvular sclerosis, which is thickening and calcification of the aortic valve. People with this condition are at higher risk for cardiovascular events and may eventually require surgery to replace the valve.

OBrien and colleagues looked at the records of 65 people who had undergone two electron beam computed tomography scans an average of two years apart. Of the group, 28 had been taking statins. People on statins had a 62 percent lower median rate of calcium accumulation.

The researchers say that because of study limitations, it is too early to recommend that people take statins to protect themselves from aortic valve calcium. However, larger studies of the question would be a good idea, OBrien said.

(Disclosure: OBrien has received speaki
'"/>

Contact: Walter Neary
wneary@u.washington.edu
206-685-3841
University of Washington
28-Mar-2002


Page: 1 2

Related medicine news :

1. Statins effective in long term, Nordic study suggests
2. Statins show early promise for treating multiple sclerosis
3. Statins and aspirin may protect against severe vision loss in elderly
4. Statins could reduce stroke risk by a third
5. International Study Finds Statins Raise Good Cholesterol, Wake Forest Physician Reports
6. HIV patients may be at risk of heart problems when taking protease inhibitor drugs
7. COX-2 inhibitors associated with blood pressure elevation
8. Older people get the big picture faster, and they are less inhibited
9. Stat5 protein inhibits spread of breast cancer cells
10. COX-2 inhibitor increases the risk of heart attack in elderly adults with no history of heart attack
11. More studies on risks and benefits of COX-2 inhibitors published in Archives of Internal Medicine

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Statins may inhibit calcium growth aortic valve the elderly

(Date:7/31/2015)... ... ... ZH Healthcare announces a new cloud based service delivering Health IT as ... Service (HITaaS) is a Healthcare dedicated cloud based service that sits over infrastructure as ... all aspects of infrastructure, security, runtime, middleware, OS, virtualization, Servers, storage, contracts, and ...
(Date:7/31/2015)... ... ... therapy for knee osteoarthritis is an important part of knee pain treatment. ... doing what they want or need to do. The patient may have trouble getting in ... exercise regime may be limited by the pain in their knee. When a patient sees ...
(Date:7/31/2015)... ... , ... New Energy Works Timberframers invites the public to join their timber ... from 9am – 12pm. Timber frame raisings are special, celebrating both craft ... the culmination of months of effort, planning, fundraising, and dreaming takes shape. , ...
(Date:7/31/2015)... , ... July 31, 2015 , ... The Radiology ... Michael Burgess, MD, (R-Tex) presenting “What’s Next for Health Care: A View From Capitol ... and founder of the Congressional Health Caucus, Rep. Burgess has a special understanding of ...
(Date:7/31/2015)... ... ... “ Crack’em ” was featured on NewsWatch as part of its monthly ... Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and shared ... can be a very messy experience, especially when cracking eggs. Cracking an egg is ...
Breaking Medicine News(10 mins):Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 3Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 3Health News:Make Less Mess while Cooking with Crack’em 2
(Date:7/30/2015)... , July 30, 2015 Eisai Inc. announced ... the United States , European Union and ... and MHLW, respectively) for eribulin, for the treatment of ... received prior chemotherapy for advanced or metastatic disease. ... from a pivotal global Phase 3 clinical trial (Study ...
(Date:7/30/2015)... 30, 2015  Medimetriks Pharmaceuticals, Inc. announced today ... III clinical study for Ozenoxacin, a novel bactericidal ... the exclusive U.S. rights to Ozenoxacin 1% cream.  ... 44 centers with an emphasis on U.S. patients, ... months and older with a clinical diagnosis of ...
(Date:7/30/2015)... FRANCISCO , July 30, 2015 ... market is expected to reach USD 23.01 million ... View Research, Inc. Growing base of geriatric population, increasing ... infections, and rising level of awareness among target customer ... rendering drivers over the forecast period. According to estimates ...
Breaking Medicine Technology:Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5
Cached News: